The Journal of Clinical Endocrinology & Metabolism · 1976 · 138 citations · 14 references
MedicineEndocrinologyPharmacologyClinical PharmacologyNeuroendocrinologyNeuropharmacologyDopaminergic PharmacologyEndocrine PharmacologyHypothalamic-pituitary RegulationPituitary Gland FunctionPituitary Hormone RegulationPituitary HormonesDopamine Inhibition Of ProlactinDopamine-mediated InhibitionHypothalamic Control Of Pituitary FunctionHypothalamic FunctionHypothalamic Hormone SecretionHypothalamic-pituitary SignalingHypothalamic-pituitary-prolactin AxisMetoclopramide Therapy
Serum prolactin concentrations increased approximately 6-fold after oral or intravenous administration of 10 mg of metoclopramide to adult men. Prolactin remained significantly elevated up to 9 h after oral metoclopramide and for at least 2 h after iv metoclopramide. Bethanechol did not increase serum prolactin, and atropine did not inhibit metoclopramide-induced prolactin elevation, suggesting that the cholinergic-like properties of metoclopramide were not responsible for the observed prolactin responses. Pre-treatment with 500 mg L-dopa inhibited the early metoclopramide-induced prolactin increase, which is consistent with the possibility that metoclopramide acts by inhibiting dopamine-mediated hypothalamic secretion of prolactin inhibitory factor. As a potent stimulus of prolactin release, metoclopramide may be useful in clinical investigation of hypothalamic-pituitary function.
14
A Homologous Radioimmunoassay for Human Prolactin1
Y. N. Sinha, F. W. SELBY, U.J. Lewis et al. · The Journal of Clinical Endocrinology & Metabolism · 1973 · 650 citations
Functional Evaluation of Prolactin Secretion: a Guide to Therapy
Henry G. Friesen, H. Guyda, P. Hwang et al. · Journal of Clinical Investigation · 1972 · 151 citations · Full text